 |
Alcaligenes xylosoxidans Bloodstream Infections in Outpatient Oncology Office CME DisclosuresRelease Date: June 27, 2008; Valid for credit through June 27, 2009 |
| Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
- Alcaligenes xylosoxidans Bloodstream Infections in Outpatient Oncology Office
Moon Kim, MD, MPH
Elizabeth Bancroft, MD, SM
Eleanor Lehnkering, MS
Rodney M. Donlan, PhD
Laurene Mascola, MD, MPH
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Identify properties of Alcaligenes xylosoxidans
- Describe the clinical presentation of A xylosoxidans infection in the current study
- Specify risk factors for infection with
A xylosoxidans
- Identify the primary source of infection with A xylosoxidans in the current study
Authors and Disclosures Moon Kim, MD, MPH
Disclosure: Moon Kim, MD, MPH, has disclosed no relevant financial relationships.
Elizabeth Bancroft, MD, SM
Disclosure: Elizabeth Bancroft, MD, SM, has disclosed no relevant financial relationships. Eleanor Lehnkering, MS
Disclosure: Eleanor Lehnkering, MS, has disclosed no relevant financial relationships. Rodney M. Donlan, PhD
Disclosure: Rodney M. Donlan, PhD, has
disclosed no relevant financial relationships. Laurene Mascola, MD, MPH
Disclosure: Laurene Mascola, MD, MPH, has disclosed that she has served has an advisor or consultant to Merck and MedImmune. Dr. Mascola has also disclosed that she has served as a speaker for Merck. Charles P. Vega, MD
Disclosure: Charles P. Vega, MD, has disclosed
that he has served as an advisor or consultant to Novartis, Inc. D. Peter Drotman, MD
Disclosure: D. Peter Drotman, MD, has disclosed no relevant financial relationships. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
